ISR's Report Benchmarks Top 50 Pharma HEOR Functions, Provides Guidance for Industry
Informing the Pharmaceutical and Biotech Industry
(firmenpresse) - CARY, NC -- (Marketwired) -- 10/24/13 -- (ISR) today announced the release of a new market research report entitled "." The report reveals operational and strategic trends in Health Economics and Outcomes Research (HEOR), allowing function managers to grow and develop better HEOR functions by leveraging the activities of many Top 50 Pharma companies.
"Changing payer requirements have resulted in significant variability and industry-wide difficulty building and structuring a high functioning HEOR department," explained Kevin Olson, CEO of ISR. "ISR's new release provides guidance for those function leaders unsure how to proceed by allowing them to leverage the HEOR activities of top 50 pharma and benchmark their own activities against these."
ISR's newest report details interviews with 17 senior HEOR decision-makers from top 50 pharmaceutical companies and details best practices, common approaches, as well as alternative styles associated with the following topics:
HEOR department operations and structuring
Organizational and operational best practices
HQ and regional structuring models
Departmental headcounts
Organizational alignment with Medical Affairs, R&D, and Market Access
Division of work (i.e. Headquarters vs. in-country affiliates, the use of "Centers of Excellence")
Involvement in pricing and reimbursement
Outsourcing and vendor selection
Annual product budgets
Challenges
Future predictions for promise, growth, models, use of service providers, etc.
Recommendations for staff, timing, payer interactions, etc.
Qualities of successful HEOR employees, as well as professional development and group structuring strategies to improve HEOR functional effectiveness
Ways to optimize HEOR work to avoid clinical development delays by identifying barriers and understanding ideal timing of HEOR project kickoff, design, and execution
For more information on ISR's "Benchmarking the Pharma Industry's HEOR Functions" report, please visit ISR's Web site at .
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about ISR's off-the-shelf intelligence and custom research offerings, please visit the company's Web site at , email , or follow ISR on Twitter .
Kevin Olson
+1 919 301 0106
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 24.10.2013 - 13:57 Uhr
Sprache: Deutsch
News-ID 1275984
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
CARY, NC
Phone:
Kategorie:
Alternative
Anmerkungen:
Diese Pressemitteilung wurde bisher 139 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ISR's Report Benchmarks Top 50 Pharma HEOR Functions, Provides Guidance for Industry
"
steht unter der journalistisch-redaktionellen Verantwortung von
Industry Standard Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
